Children's Wisconsin is among the top centers in the world for the treatment of pediatric cancer, with the capability and resources available to conduct early-phase (Phase I and II) clinical trials. As a member of several early-phase research consortia, Children's Wisconsin offers patients and families access to new, innovative treatment options. In addition, we offer several early phase studies developed by our own researchers as well as multi-center clinical trials initiated by our partners at leading programs around the country.
Some of our recent investigator-initiated clinical trials include:
- Phase 1 study of bispecific CAR-T cells for patients with relapsed or refractory CD19 or CD20 B-cell Acute Lymphoblastic Leukemia
- Parent-to-Child (Haplo) Transplant for patients with sickle cell disease